Prior to Accumetrics, Mr Tibbitts served as CFO of CryoCor, a medical device company. Before joining CryoCor, Mr Tibbitts served as CFO of Elitra Pharmaceuticals, a biotechnology company, and as a senior manager in the audit practice of Ernst & Young.
Mr Tibbitts has received a BBA degree from the University of San Diego, and an MBA from San Diego State University, and serves on the board of directors of IDMI Pharmaceuticals, a biotechnology company.
Timothy Still, CEO of Accumetrics, said: “We believe Greg’s extensive experience in both private and public companies will help Accumetrics to advance our financial operations and bring continued success to the company. His deep knowledge of the capital markets and the medical device arena will be important as we maximize the commercial opportunity for our technology.”